USGI Medical

USGI Medical is a medical technology company that specializes in incisionless, endoscopic surgical procedures. Their focus is on treatments for weight loss, gastroesophageal reflux disease (GERD), and advanced therapeutic endoscopy. The company aims to reduce patient recovery time and procedural risks by utilizing natural body passageways for surgery, eliminating the need for external incisions. The flagship technology platform, the Incisionless Operating Platform™, includes devices like the g-Cath™ EZ Delivery Catheter and Snowshoe™ Suture Anchors, which have received U.S. 510(k) clearance and CE Mark approval. USGI Medical has conducted significant clinical research, including the ESSENTIAL Trial™, which evaluates the effectiveness of their endoscopic weight loss procedure, POSE™ (Primary Obesity Surgery, Endolumenal). This trial supports FDA approval for weight loss indications. Led by a team with extensive experience in medical devices and healthcare investment, USGI Medical provides innovative solutions for healthcare providers specializing in gastroenterology and bariatric medicine. Their technologies offer patients less invasive options for managing obesity and reflux disease.

• Employees 36
• Founded 2001
• Annual Revenue $8000000
• Total Funding $30900000